Tissue examination to monitor antiangiogenic therapy: a phase I clinical trial with endostatin.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (36)
Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
1996 • 6,878 citations
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
1997 • 4,504 citations
Tumors: Wounds That Do Not Heal
1986 • 4,202 citations
Requirement of Vascular Integrin α v β 3 for Angiogenesis
1994 • 3,016 citations
Genes Expressed in Human Tumor Endothelium
2000 • 1,838 citations
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
1997 • 1,705 citations
Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.
2000 • 1,536 citations
Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
1999 • 1,248 citations
A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF
1998 • 1,239 citations
Angiostatin induces and sustains dormancy of human primary tumors in mice
1996 • 1,193 citations
Tumor angiogenesis: past, present and the near future
2000 • 973 citations
Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.
2000 • 750 citations
Vascular endothelial growth factor is essential for corpus luteum angiogenesis
1998 • 641 citations
Endostatin Induces Endothelial Cell Apoptosis
1999 • 594 citations
Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding
1999 • 451 citations
Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.
2000 • 416 citations
Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: Role of vascular endothelial growth factor
1998 • 378 citations
Fighting Cancer by Attacking its Blood Supply
1996 • 331 citations
Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase.
2000 • 316 citations
Cell Surface Glypicans Are Low-Affinity Endostatin Receptors
2001 • 310 citations
Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene
1999 • 301 citations
Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs.-host reaction.
1975 • 285 citations
Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis
2000 • 273 citations
Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma.
1999 • 246 citations
Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity
2000 • 215 citations
Crystal structure of the angiogenesis inhibitor endostatin at 1.5Aresolution
1998 • 209 citations
Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice
2000 • 206 citations
Antiangiogenesis signals by endostatin
2001 • 198 citations
Cloning, Expression, andin VitroActivity of Human Endostatin
1999 • 188 citations
The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing
2000 • 170 citations
The Angiogenesis Inhibitor, Endostatin, Does Not Affect Murine Cutaneous Wound Healing
2000 • 108 citations
Inhibitory Effect of Full-Length Human Endostatin on in Vitro Angiogenesis
1999 • 82 citations
Disruption of the KEX1 gene inPichia pastoris allows expression of full-length murine and human endostatin
1999 • 64 citations
Angiogenesis Inhibitor TNP-470 Inhibits Murine Cutaneous Wound Healing
1999 • 63 citations
Endostatin Binds to Blood Vessels in Situ. Independent of Heparan Sulfate and Does Not Compete for Fibroblast Growth Factor-2 Binding
1999 • 61 citations
Angiogenesis inhibitor TNP-470 prevents implanted liver metastases after partial hepatectomy in an experimental model without impairing wound healing
1996 • 23 citations